Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence
The Journal of Nervous and Mental Disease,  Clinical Article

Ralevski E et al. – The objectives of this study were to examine the effect of acamprosate treatment on cognition and to assess whether the changes in drinking patterns or psychotic symptoms were related to changes in cognitive functioning.


  • 23 Outpatients with schizophrenia spectrum disorders and alcohol dependence
  • Randomized (double-blind) to either acamprosate or placebo treatment for 12 weeks
  • Assessments (baseline and week 12) included alcohol use, symptoms of psychosis, memory, and attention


  • Results showed that acamprosate had no effect on cognitive functioning
  • No relationship between change in alcohol consumption or psychotic symptoms and change in cognitive functioning in this sample of patients

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More